Abstract:BACKGROUND:Since the Fas/Fas Ligand (FasL) interaction is recognized as a major pathway of apoptosis in immune cells, we hypothesized that selective expression of FasL by tubular cells (TC) may promote the resolution of interstitial inflammation by inducing apoptosis of infiltrating immune cells. In this study, the effect of FasL transfection of rat TC on apoptosis of leukocytes was examined.METHODS:Rat tubule cells (NRK52E) were transfected with plasmids constructed using human and rat FasL (hFasL and rFasL). The propensity of activated, transfected TC to undergo apoptosis was examined. Similarly, the effects of FasL transfection on apoptosis of Jurkat cells and activated leukocytes were assessed directly following co-culture for 12 hours and in a cell insert system intended to assess the effects of soluble FasL. Fas and FasL expression was assessed by flow cytometry and apoptosis was examined using Annexin V staining and the TUNEL method.RESULTS:Expression of FasL in TC was increased after FasL transfection. Transfected TC showed no detectable increase in apoptosis following lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-alpha) activation. Jurkat cell apoptosis was increased ninefold and eightfold after co-culture with TC transfected with hFasL and rFasL, respectively (67.0 +/- 12.1% and 60.1 +/- 8.8% vs. 6.7 +/- 1.8% with un-transfected TC, P < 0.01). Similarly, apoptosis of activated leukocytes was increased fourfold by co-culture (26.8 +/- 4.9% vs. 6.7 +/- 2.0% with untransfected TC, P < 0.01). Leukocyte apoptosis also was increased in an insert culture system (18.2 +/- 4.4% vs. 5.8 +/- 2.3% with un- transfected TC, P < 0.01). No increase of TC apoptosis was detected in any of the co-culture experiments.CONCLUSION:Enhanced expression of FasL by TC is capable of inducing apoptosis of activated leukocytes, without evidence for increased susceptibility to apoptosis of the transfected cells themselves. This suggests a potential role for this approach in the limitation and resolution of renal tubulointerstitial inflammation.

FcμR (toso/faim3) is Not an Inhibitor of Fas-mediated Cell Death in Mouse T and B Cells

Fc Mu R (Toso/Faim3) Is Not An Inhibitor Of Fas-Mediated Cell Death In Mouse T And B Cells

The Fas Ligand As a Cell Death Factor and Signal Transducer

Considering Fas ligand as a target for therapy.

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Activation‐dependent FasL Expression in T Lymphocytes and Natural Killer Cells

Splenic Stroma-Educated Regulatory Dendritic Cells Induce Apoptosis of Activated CD4 T Cells Via Fas Ligand-Enhanced IFN-γ and Nitric Oxide.

Apoptosis in Ichthyophthirius Multifiliis is Associated with Expression of the Fas Receptor of Theronts

FcμR interacts and cooperates with the B cell receptor To promote B cell survival.

Nomenclature of Toso, Fas Apoptosis Inhibitory Molecule 3, and IgM FcR.

The death receptor Fas mediates a non-apoptotic signaling cascade in apoptosis resistant CD4+ T cells via the MAPK pathway. (P1304)

Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Regulation of Bcl-Xl Expression and Fas Susceptibility in Mouse B Cells by CD40 Ligation, Surface IgM Crosslinking and IL-4.

ENHANCEMENT OF SUSCEPTIBILITY TO FAS-MEDIATED APOPTOSIS OF TH1 CELLS BY NONMITOGENIC ANTI-CD3?? F(ab???) 21

Transfection of Tubule Cells with Fas Ligand Causes Leukocyte Apoptosis

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

Apoptosis and Potential Immunoregulation Mediated by Fas Molecular

TUMOUR NECROSIS FACTOR-INDUCED NECROSIS VERSUS ANTI-Fas-INDUCED APOPTOSIS IN L929 CELLS

Fcµ Receptor Promotes the Survival and Activation of Marginal Zone B Cells and Protects Mice Against Bacterial Sepsis.

Effect of Fas/FasL on immune/inflammation response in central nervous system

Identifying Fas/Cd95 Non-Apoptotic Signaling Pathways Associated with T Cell Differentiation